Physician profile
James Holtzclaw
NPI 1275584930
$5,876.98
in general payments reported to CMS, 2019-2025
7 companies · $88.32 in 2025
The $88.32 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $34.83 · 2021: $1,227 · 2022: $14.74 · 2023: $1,819 · 2024: $2,145 · 2025: $88.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,625 · Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,625.05 |
| Food and Beverage | $1,426.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,997.67 | 2020-2025 | Journey II, Real Intelligence, Ri Hip Navigation |
| Zimmer Biomet Holdings, INC. | $430.90 | 2019 | |
| Depuy Synthes Sales INC. | $200.43 | 2021-2023 | Velys, Tfn-Advance |
| Boston Scientific Corporation | $116.99 | 2019 | |
| Amgen INC. | $90.35 | 2024-2025 | Krystexxa |
| Medacta USA, INC. | $25.90 | 2020-2021 | |
| Horizon Therapeutics Plc | $14.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Holtzclaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.